Healthcare provider profile · identity verified

Joseph Edward Orgeron, MD

Family Practice · LAFAYETTE, LA · NPI 1215032479

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	572	166
Amlodipine Besylate	Amlodipine Besylate	399	126
Levothyroxine Sodium	Levothyroxine Sodium	397	106
Pantoprazole Sodium	Pantoprazole Sodium	279	93
Losartan Potassium	Losartan Potassium	254	87
Metoprolol Succinate	Metoprolol Succinate	236	68
Omeprazole	Omeprazole	233	66
Trazodone Hcl	Trazodone Hcl	227	59
Rosuvastatin Calcium	Rosuvastatin Calcium	224	73
Tamsulosin Hcl	Tamsulosin Hcl	203	65
Lisinopril	Lisinopril	192	62
Ozempic	Semaglutide	167	32
Gabapentin	Gabapentin	164	54
Metformin Hcl	Metformin Hcl	152	48
Pravastatin Sodium	Pravastatin Sodium	144	43
Hydrochlorothiazide	Hydrochlorothiazide	143	48
Furosemide	Furosemide	136	45
Duloxetine Hcl	Duloxetine Hcl	135	36
Allopurinol	Allopurinol	130	37
Escitalopram Oxalate	Escitalopram Oxalate	122	44
Sertraline Hcl	Sertraline Hcl	113	37
Carvedilol	Carvedilol	110	32
Eliquis	Apixaban	110	30
Potassium Chloride	Potassium Chloride	107	29
Simvastatin	Simvastatin	103	31
Alprazolam	Alprazolam	98	34
Eszopiclone	Eszopiclone	98	15
Olmesartan Medoxomil	Olmesartan Medoxomil	97	32
Albuterol Sulfate Hfa	Albuterol Sulfate	95	37
Alendronate Sodium	Alendronate Sodium	95	30
Fluticasone Propionate	Fluticasone Propionate	95	40
Mounjaro	Tirzepatide	88	16
Montelukast Sodium	Montelukast Sodium	85	26
Tizanidine Hcl	Tizanidine Hcl	83	27
Clopidogrel	Clopidogrel Bisulfate	78	30
Famotidine	Famotidine	77	26
Meloxicam	Meloxicam	77	23
Metoprolol Tartrate	Metoprolol Tartrate	76	23
Metformin Hcl Er	Metformin Hcl	72	24
Glimepiride	Glimepiride	68	25
Ondansetron Odt	Ondansetron	67	22
Celecoxib	Celecoxib	66	18
Valsartan	Valsartan	65	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	19
Fluoxetine Hcl	Fluoxetine Hcl	52	21
Ezetimibe	Ezetimibe	50	18
Synthroid	Levothyroxine Sodium	50	15
Venlafaxine Hcl Er	Venlafaxine Hcl	50	15
Jardiance	Empagliflozin	49	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	18
Chlorthalidone	Chlorthalidone	43	15
Spironolactone	Spironolactone	42	12
Buspirone Hcl	Buspirone Hcl	41	14
Citalopram Hbr	Citalopram Hydrobromide	41	13
Estradiol	Estradiol	41	13
Atenolol	Atenolol	40	16
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	40	11
Finasteride	Finasteride	38	12
Irbesartan	Irbesartan	38	suppressed
Azelastine Hcl	Azelastine Hcl	37	20
Breo Ellipta	Fluticasone/Vilanterol	37	11
Diclofenac Sodium	Diclofenac Sodium	37	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	37	suppressed
Prednisone	Prednisone	35	25
Propranolol Hcl	Propranolol Hcl	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Mirtazapine	Mirtazapine	34	11
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	11
Nifedipine Er	Nifedipine	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	11
Meclizine Hcl	Meclizine Hcl	30	15
Bupropion Xl	Bupropion Hcl	28	suppressed
Ramipril	Ramipril	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Naproxen	Naproxen	23	15
Valacyclovir	Valacyclovir Hcl	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	20
Linzess	Linaclotide	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	12
Ibandronate Sodium	Ibandronate Sodium	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Nebivolol Hcl	Nebivolol Hcl	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Premarin	Estrogens, Conjugated	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Glipizide	Glipizide	18	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Nystatin	Nystatin	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Diazepam	Diazepam	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	16
Topiramate	Topiramate	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	11
Enalapril Maleate	Enalapril Maleate	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Armour Thyroid	Thyroid,pork	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Digoxin	Digoxin	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Tadalafil	Tadalafil	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error